ArticleRespiratory research2026
Immunophenotypic and structural signatures of severe granulation tissue in airway implant patients.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGranulation tissue formation is a frequent complication following airway implant procedures such as endobronchial valve (EBV) therapy in patients with chronic obstructive pulmonary disease (COPD). This hyperplastic response can impair implant function and clinical outcomes, yet the underlying immunological mechanisms remain poorly understood.
methodsIn a cohort of EBV patients (n = 147), we developed an optical scaling and scoring system to classify the severity of granulation tissue in relation to clinical outcomes. Based on this system, we prospectively collected endobronchial biopsies from EBV (n = 41) and stent patients (n = 11) for immune and structural profiling across different severity grades. Granulation tissue was analysed by histology, immunofluorescence, and flow cytometry.
resultsUsing the optical scoring system, almost 75% of EBV patients developed hyperplastic granulation tissue (34.7% moderate, 38.8% severe). In many moderate to severe cases, valve dysfunction, dislocation, and the need for revision was observed. Increasing severity of granulation tissue was associated with profound extracellular matrix (ECM) disruption and increased immune cell infiltration. Immunophenotyping revealed elevated neutrophils and regulatory T cells (Tregs) with a central memory phenotype. Macrophages in patients with severe granulation tissue formation showed a shift toward a CD163+ M2-like polarisation. Structural analyses demonstrated a loss of epithelial integrity and an upregulation of ECM remodelling markers, fibronectin, and tenascin C.
conclusionThis study provides the first systematic immune-morphological classification of airway granulation tissue following EBV therapy. Our findings revealed distinct immune and ECM signatures associated with clinical complications identify potential mechanisms and therapeutic targets, particularly relevant for COPD patients in whom current anti-inflammatory strategies are insufficient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.